G. J. A. Offerhaus - Concepedia

Author

G. J. A. Offerhaus

Amsterdam UMC Location University of Amsterdam

Also Known As

G J A Offerhaus, G J Offerhaus, G Johan A Offerhaus, G Johan Offerhaus, G OFFERHAUS, G Offerhaus, G. J. A. Offerhaus, G. J. A. Offerhaus, M.D., Ph.D., G. J.A. Offerhaus, G. Johan A. Offerhaus

109

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University of Amsterdam Johns Hopkins University University Medical Center Utrecht Johns Hopkins Medicine

About

G. J. A. Offerhaus is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	22	3.8K
2	Public Health	3	3	186
3	Biochemistry	2	2	1.6K
4	Health Sciences	1	1	320
5	Allergy	1	1	52

G. J. A. Offerhaus

Publications

Citations

H-Index

Page 1

	Year	Citations
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Jasper Smit, Alfred H. Schinkel, Ronald P.J. Oude Elferink, Cell HepatologyBiochemistryBiliary TractLiver PhysiologyComplete Absence	1993	1.5K
Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia K. Nadine Phoa, Frederike G.I. van Vilsteren, Bas L. Weusten, JAMA	2014	627
Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma Johanna W. van Sandick, J. Jan B. van Lanschot, B. W. Kuiken, Gut	1998	396
Leptin Is a Growth Factor for Colonic Epithelial Cells James C.H. Hardwick, Gijs R. van den Brink, G. J. A. Offerhaus, Gastroenterology InflammationGastrointestinal Peptide HormoneGrowth FactorCytoskeletonGut Barrier	2001	367
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Robb E. Wilentz, Joseph Geradts, Robert Maynard, PubMed PathologyCancer BiologyTumor BiologyTranscriptional RegulationPancreatic Cancer	1998	340
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema, The Lancet Oncology Residual DiseaseSurgical OncologyEsophageal CancerGastrointestinal OncologyMedicine	2018	320
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis Evelien Dekker, F. van den Broek, Johannes B. Reitsma, Endoscopy	2007	308
Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Michael Goggins, G. J. A. Offerhaus, Werner Hilgers, PubMed	1998	271
Risk of colorectal cancer in juvenile polyposis L. A. A. Brosens, Arnout van Hattem, Linda M. Hylind, Gut	2007	271
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. William H. Westra, Inge O. Baas, R.H. Hruban, PubMed Advanced Lung DiseaseLung InflammationGeneticsPathologyPulmonary Alveolar Proteinosis	1996	224

Page 1